This activity is expired and is no longer available for CME credit.


Making Informed Decisions When Screening and Monitoring

Author(s)/Faculty: Thomas P. Leist, MD, PhD
Release Date: 12/17/2014Expiration Date: 11/12/2016
Credit Type: CMENumber of Credits: 0
Content Type: MonographProvider:
Since the approval of interferon beta-1b, multiple additional therapies have become available for the treatment of multiple sclerosis. These agents vary in safety and utilize a variety of mechanisms of action, most of which are anti-inflammatory. Therapy for multiple sclerosis must be tailored to each individual patient, while taking into consideration patient-related factors such as disease stage and adherence concerns. Treatment-related issues such as efficacy and safety must also be factored into the decision. This supplement will provide insight on how to use data on available therapies to drive clinical decision making for patients with multiple sclerosis.